ESC 365 - Clinical perspectives: raising suspicion and diagnosing ATTR-CM in patients with heart failure.

Open Access

Clinical perspectives: raising suspicion and diagnosing ATTR-CM in patients with heart failure.

Session: Looking beyond heart failure: could it be transthyretin amyloid cardiomyopathy (ATTR-CM)?

Topic: Cardiac Diseases

Speaker: Associate Professor A. Pollak (Jerusalem, IL)

Sponsored by Pfizer

Event: Heart Failure 2022

Congress Presentation

About the speaker

Associate Professor Arthur Pollak

Hadassah - Hebrew University Medical Center Jerusalem, Jerusalem (Israel)

1 presentation

0 follower

3 more presentations in this session

Heart failure or ATTR-CM? The importance of early diagnosis.

Speaker: Doctor J. Gonzalez-Costello (Hospitalet De Llobregat, ES)

Long-term management of patients with ATTR-CM.

Speaker: Professor C. Rapezzi (Ferrara, IT)

Panel discussion and Q&A.

Access the full session

Looking beyond heart failure: could it be transthyretin amyloid cardiomyopathy (ATTR-CM)?

Speakers: Associate Professor A. Pollak, Doctor J. Gonzalez-Costello, Professor C. Rapezzi

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by